What is the address of MEDIGAUME?

The registered office of MEDIGAUME is located at Rue des Combattants 17, 6760 Virton.

Is MEDIGAUME still active?

Yes. According to the CBE (17 September 2026) MEDIGAUME is active, legal situation “Normale toestand”, started on 10 January 1996.

Is MEDIGAUME registered on Peppol?

No, MEDIGAUME is currently not registered on the Peppol network.

What is the enterprise number of MEDIGAUME?

The enterprise number of MEDIGAUME is BE0456998672.

When was MEDIGAUME founded?

MEDIGAUME was founded on 10 January 1996.

Who are the directors of MEDIGAUME?

According to the 2025 annual accounts, the directors of MEDIGAUME are: BENOIT HENRY.

Is MEDIGAUME a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 January 1996; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDIGAUME make in 2025?

MEDIGAUME posted a profit after taxes of € 6,687 in financial year 2025.

What is the revenue of MEDIGAUME?

As a small company, MEDIGAUME is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 8,277.

MEDIGAUME (Private Limited) - Virton - BE0456998672

Dossier MEDIGAUME, printed on 17 September 2026 from databakkes.be/en/0456998672/medigaume. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MEDIGAUME from Virton, company number BE0456998672, closed financial year 2025 with a result of € 6,687 after tax. For that financial year MEDIGAUME recorded a gross margin of € 8,277 and equity of € 177,584. Compared with financial year 2024, the result moved from € 744 to € 6,687. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 177,584

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 6,687

▲ € 5,944 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 556

▲ € 507 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 71,687.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

€ 17,161

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 13,896

▲ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 6,788 Gross margin 2022: € 6,788 First fiscal year in the series	€ 8,153 Gross margin 2023: € 8,153 ▲ 20% vs 2022 (€ 6,788) Favourable step	€ 2,168 Gross margin 2024: € 2,168 ▼ 73% vs 2023 (€ 8,153) Unfavourable step	€ 8,277 Gross margin 2025: € 8,277 ▲ 282% vs 2024 (€ 2,168) Favourable step	▲ 282%
Profit after taxes	€ -11,271 Profit after taxes 2022: € -11,271 First fiscal year in the series	€ -9,637 Profit after taxes 2023: € -9,637 ▲ € 1,633 vs 2022 (€ -11,271) Favourable step	€ 744 Profit after taxes 2024: € 744 ▲ € 10,381 vs 2023 (€ -9,637) Favourable step	€ 6,687 Profit after taxes 2025: € 6,687 ▲ € 5,944 vs 2024 (€ 744) Favourable step	▲ € 5,944
Equity	€ 179,790 Equity 2022: € 179,790 First fiscal year in the series	€ 170,153 Equity 2023: € 170,153 ▼ 5% vs 2022 (€ 179,790) Unfavourable step	€ 170,897 Equity 2024: € 170,897 Unchanged (€ 170,153) Favourable step	€ 177,584 Equity 2025: € 177,584 ▲ 4% vs 2024 (€ 170,897) Favourable step	▲ 4%
Total debts	€ 104,855 Total debts 2022: € 104,855 First fiscal year in the series	€ 140,565 Total debts 2023: € 140,565 ▲ 34% vs 2022 (€ 104,855) Unfavourable step	€ 13,218 Total debts 2024: € 13,218 ▼ 91% vs 2023 (€ 140,565) Favourable step	€ 31,057 Total debts 2025: € 31,057 ▲ 135% vs 2024 (€ 13,218) Unfavourable step	▲ 135%
Cash	€ 390 Cash 2022: € 390 First fiscal year in the series	€ 52 Cash 2023: € 52 ▼ 87% vs 2022 (€ 390) Unfavourable step	€ 49 Cash 2024: € 49 ▼ 5% vs 2023 (€ 52) Unfavourable step	€ 556 Cash 2025: € 556 ▲ € 507 vs 2024 (€ 49) Favourable step	▲ € 507
Land & buildings	€ 199,303 Land & buildings 2022: € 199,303 First fiscal year in the series	€ 184,740 Land & buildings 2023: € 184,740 ▼ 7% vs 2022 (€ 199,303) Unchanged	-	-
Retained profit	€ 73,894 Retained profit 2022: € 73,894 First fiscal year in the series	€ 64,256 Retained profit 2023: € 64,256 ▼ 13% vs 2022 (€ 73,894) Unfavourable step	€ 65,000 Retained profit 2024: € 65,000 ▲ 1% vs 2023 (€ 64,256) Favourable step	€ 71,687 Retained profit 2025: € 71,687 ▲ 10% vs 2024 (€ 65,000) Favourable step	▲ 10%
Bank debt	€ 52,341 Bank debt 2022: € 52,341 First fiscal year in the series	€ 41,088 Bank debt 2023: € 41,088 ▼ 21% vs 2022 (€ 52,341) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 41,088) Favourable step	€ 17,161 Bank debt 2025: € 17,161 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 284,645 Balance sheet total 2022: € 284,645 First fiscal year in the series	€ 310,718 Balance sheet total 2023: € 310,718 ▲ 9% vs 2022 (€ 284,645) Unchanged	€ 184,115 Balance sheet total 2024: € 184,115 ▼ 41% vs 2023 (€ 310,718) Unchanged	€ 208,641 Balance sheet total 2025: € 208,641 ▲ 13% vs 2024 (€ 184,115) Unchanged	▲ 13%

Key figures of MEDIGAUME, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDIGAUME?

What happened at MEDIGAUME in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 6,687 (▲ € 5,944 vs 2024). filed late Source: NBB ↗
Jan 10, 1996 Start of the company according to the CBE. KBO

In short

From € 11,271 loss in 2022 to € 6,687 profit in 2025.

Best year ever: 2025, with € 6,687 profit.

Original PDFs at the National Bank ↗

A new publication or filing at MEDIGAUME? We notify you, reason included.

Follow MEDIGAUME

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit